An app to help men do exercises to strengthen their pelvic floor muscles.
What does the app do?
The app comes preset with a standard set of exercises, but it can be personalised with a programme set by a specialist physiotherapist. It reminds you when you need to exercise and you can record the number of exercises you've completed. The app has visual and audio features to help you with your programme.
For the app description, go to App website, Google Play, iTunes and for a detailed review, see Reviews.
✔ Developed with input from Women’s Health Physiotherapists, uses evidence-based research and is approved by the NHS (public health system in the UK)
✔ Visual and auditory guided pelvic floor exercises. Has a default exercise program with both quick and slow contractions. This can be customised by a physiotherapist.
✔ Exercises are recorded automatically so you can track your progress.
✔ Has reminders
✘ Costs $6.49
✘ A financial grant was received from a drug company, but it was unrestricted, and I could not find any mention of medication.
✘ Can’t export exercise records.
✘ No bladder diary like with the squeezy app for women.
✘ No section on bladder retraining for those with urge incontinence.
✘ It could do with more information, such as information on other treatment options for erectile dysfunction and incontinence.
Privacy and security
Date of review: September 2018
Platform reviewed: Android
Download size: 1.3 MB
Updated on: April 2017
Did you find this information useful?
Disclaimer: Health Navigator’s app library is a free consumer service to help you decide whether a health app would be suitable for you. Our review process is independent. We have no relationship with the app developers or companies and no responsibility for the service they provide. This means that if you have an issue with one of the apps we have reviewed, you will need to contact the app developer or company directly.
Reviewer: Jeremy Steinberg, GP, RNZCGP
Date of review: September 2018
Comments: This app is for men with erectile dysfunction and potentially those with urinary incontinence. However pelvic floor exercises are not commonly recommended in men. This app is the cousin to the women’s “Squeezy” app for pelvic floor exercises. Its features are similar except that the men’s version does not include a bladder diary.
The app helps men do pelvic floor exercises, and it does this very well. It allows for a self-guided or physiotherapist-guided exercise program, instructions and reminders. Pelvic floor exercises are not commonly recommended for men unlike with women, where incontinence is much rarer. There is some limited evidence that it can be helpful for erectile dysfunction and so it could be considered in this context.1 Trials on urinary incontinence have tended to focus on treatment following prostatectomy, and they have not shown consistent benefit for improvement of urinary incontinence.2 The app neglects to mention this.
The information is very similar across the two versions, and so I would recommend buying the women’s version instead because of the extra features. There is not very much information relevant to men. It costs $6.49 with there being no free version available.Unfortunately, neither version include a section of bladder retraining which could be helpful for those with urge incontinence. If you have urinary incontinence, see your doctor in the first instance.
Safety concerns: No safety concerns. There is information about when you should see your doctor.
New Zealand relevance: Developed for the NHS in the UK, however it is still definitely relevant for the NZ context. It also has links to relevant organisations in NZ.
- Dorey G, Speakman MJ, Feneley RCL, Swinkels A, Dunn CDR. Pelvic floor exercises for erectile dysfunction. BJU Int. 2005 Sep 1;96(4):595–7.
- Glazener C, Boachie C, Buckley B, Cochran C, Dorey G, Grant A, et al. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials. Lancet Lond Engl. 2011 Jul 23;378(9788):328–37.